Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$483062.0.

  • Evoke Pharma's Net Cash Flow fell 12235.16% to -$483062.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $236978.0, marking a year-over-year decrease of 9568.62%. This contributed to the annual value of $8.9 million for FY2024, which is 27352.47% up from last year.
  • Evoke Pharma's Net Cash Flow amounted to -$483062.0 in Q3 2025, which was down 12235.16% from -$565018.0 recorded in Q2 2025.
  • Over the past 5 years, Evoke Pharma's Net Cash Flow peaked at $10.1 million during Q1 2021, and registered a low of -$5.6 million during Q3 2021.
  • In the last 5 years, Evoke Pharma's Net Cash Flow had a median value of -$1.0 million in 2023 and averaged $190861.4.
  • The largest annual percentage gain for Evoke Pharma's Net Cash Flow in the last 5 years was 76096.55% (2021), contrasted with its biggest fall of 22630.95% (2021).
  • Evoke Pharma's Net Cash Flow (Quarter) stood at -$2.0 million in 2021, then dropped by 25.49% to -$2.5 million in 2022, then skyrocketed by 55.87% to -$1.1 million in 2023, then soared by 304.1% to $2.3 million in 2024, then crashed by 121.4% to -$483062.0 in 2025.
  • Its last three reported values are -$483062.0 in Q3 2025, -$565018.0 for Q2 2025, and -$972510.0 during Q1 2025.